Big concern. Merck can now produce a solution for hep C and it may have an attractive price and insurers may steer patients away from Solvadi.
Small concern. The patent infringement could have more clout with combining both companies.
So all the analysts were apparently allowed to give their analysis earlier in the week. The consensus was very good. Then over the following three days the pps just comes straight down. Can someone please explain? thanks,
Help requested: while feeling "right" about future of ag, yet having no idea where to invest. Looking at PAGG an etf with holdings in all the main players (looks to be even stronger than MOO). Or one/two companies? Thanks in advance,
How is this good business? Is it pressure from larger reseller client(s)? A reason would be nice.